ABSTRACT. Developing portable and low-cost methods for quantitative detection of large protein biomarkers and small molecular toxins can play a significant role in controlling and preventing diseases or toxins outbreaks. Despite years of research, most current methods still require laboratory-based or customized devices that are not widely available to the general public for quantitative analysis. We have previously demonstrated the use of personal glucose meters (PGMs) and functional DNAs for the detection of many non-glucose targets. However, the range of targets detectable by functional DNAs is limited at the current stage. To expand the range of targets that can be detected by PGMs, we report here the use of antibodies in combination with sandwich and competitive assays for quantitative detection of protein biomarkers (PSA, with a detection limit of 0.4 ng/mL) and small molecular toxins (Ochratoxin A, with a detection limit of 6.8 ng/mL), respectively. In both assay methods, with invertase conjugates as the link, quantitative detection is achieved via the dependence between the concentrations of the
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INTRODUCTION
Affordable medical diagnostics and toxin monitoring at home or in the field are playing an increasingly important role in modern healthcare, as it can result in early detection, allow timely intervention to prevent wide-spread of diseases or toxins and facilitate personalized medicine. It will also bridge the gap between the well-offs and the poor, as well as between those living in urban area and those in rural and remote areas where access to clinical labs is limited, if not impossible. 1 Toward this goal, much effort has been devoted toward developing in-home medical tests, such as the pregnancy test.
However, most of these tests are qualitative based on colorimetry, even though quantitative numbers are more helpful or even required in diagnosis of many other diseases or detection of toxins. To overcome this limitation, a number of portable quantitative tests have been developed. Despite tremendous progress made in the past decades, few such devices are widely available to the public and most people have to go to hospitals or clinical labs for diagnosis.
One ideal device that can meet the above challenge is personal glucose meter (PGM). [2] [3] [4] Compared to most other devices, PGMs are successful for in-home medical diagnostics not only because of their portable pocked size, low cost, simple operation and reliable quantitative results, but more importantly, also for its wide accessibility to the public worldwide. PGMs are commercially available in stores everywhere, and their recent integration in cell phones may give PGMs an even larger number of users. 5 However, the current PGMs can only be used by the diabetes to monitor blood glucose. To overcome this limitation, several groups have reported modifications of PGMs in order to make them measure targets beyond glucose. 6, 7 For example, the enzyme inside test strips of PGMs has been replaced with other enzymes that catalyze the redox reactions of alcohols, lactates and ornithine, instead of glucose, to quantify these substrates with the modified PGMs or other customized devices. 6,7 While 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   3 these results are encouraging, it is preferable not to modify the PGMs so that any of the available PGMs at home or in the market can be used by the public. In a recent publication, we reported the use of commercial PGMs for quantitative detection of many non-glucose analytes using invertases conjugated to functional DNAs such as aptamers and DNAzymes, 8 and the concept has also been applied for the development of a new method to quantify DNA using PGMs. 9 In both cases, a direct relationship could be established between the concentrations of the targets in the samples and the glucose detected by
PGMs. An important feature of the methods is that no modification of the PGM itself is required so that any commercial PGM can be used. While it is important to develop a new method to take advantage of the much broader scope of targets that antibodies can bind for potential in-home diagnosis and detection using PGMs, the methods 4 demonstrated previously in our group 8,9 based on the differences of DNA melting temperatures before and after the binding of the target or the DNA hybridization cannot be directly applied to PGM detection using antibodies, since no such enzymatic cleavage or conformational change upon target binding can be easily engineered into antibodies. Therefore a new challenge of signal transduction has to be overcome in order for antibodies to be used as a general platform for detecting non-glucose analytes using PGMs.
Herein we present two general strategies of sandwich and competitive assays to use antibody-coated
MBs for the detection of large protein biomarkers such as prostate-specific antigen (PSA) and small toxic molecules such as ochratoxin A, respectively. 
RESULTS AND DISCUSSION
Detection of large protein biomarkers by PGM using a sandwich assay method.
To expand the scope of targets detectable by PGMs, we first choose antibodies that can bind protein biomarkers, as protein biomarkers are ubiquitous for medical diagnostics. 16, [22] [23] [24] To use antibodies for protein biomarkers in PGMs, we applied a sandwich assay method that utilized antibodycoated magnetic beads (MBs) (Figure 1 ). If the target (streptavidin or prostate specific antigen (PSA)) is present in the sample, it will bind to both the antibody-coated MBs and the antibody-conjugated invertase (here biotin is considered as "antibody" to bind the target strepavidin just like anti-PSA binds PSA) to form the sandwich complex ( Figure 1 ). After magnetic separation from the solution, the resulting sandwich complex containing invertase conjugates bound on the MBs can be used to hydrolyze
PGMs-inert sucrose into glucose, thus establishing direct correlation between the concentrations of the targets in the samples and the glucose monitored by PGMs, with glucose signal enhanced for the sandwich assay in the presence of the target ( Figure 1 ). In the absence of the target, however, the 6 formation of sandwich complex will not occur and no invertase could carry out the sucrose hydrolysis reactions after magnetic separation, therefore little glucose signal can be measured by PGMs. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 7
The proof-of-concept experiment shown above using PGMs to detect streptavidin encouraged us to apply the successful methodology to develop PGM-based sandwich assays to detect protein biomarkers of interest in medical diagnostics, i.e., prostate specific antigen (PSA), 12,25-28 which is a FDA-approved biomarker for prostate cancer. The PSA detection using this method was carried out in both Buffer B (Phosphate buffered saline (PBS, pH 7.0, 137 mM NaCl, 2.7 mM KCl, 8 mM Na 2 HPO4, 1.8 mM KH 2 PO4), 0.025% Tween-20, 1 g/L BSA) and 25% human serum diluted by Buffer B. As shown in Figure 3 , in both cases, increasing amounts of PSA in the sample resulted in a higher glucose read out in the PGMs, with a detection range at least within 0~100 ng/mL PSA. Detection limits as low as 0.4 and 1.5 ng/mL were obtained from the data for the PSA detections in Buffer B (Figure 3a ) and 25% human serum ( Figure   3b 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 9 assay buffers and human serum (HSA) as high as 100 mg/L gave neglectable response in PGMs under the same condition, the assay was selective to PSA over BSA or HSA as control proteins. Detection of small molecular targets by PGM using a competitive assay method.
The above sandwich assay method can be very efficient when the target has multiple binding sites for at least two separated antibodies. For example, each streptavidin in Figure 1a has at least two (ideally four) binding sites for biotin, so the sandwich complex can be formed via the biotinstreptavidin-biotin mode. Other macromolecular analytes such as proteins biomarkers, nucleic acids and polysaccharides can also be assayed using the similar mechanism. However, when the target of interest has only one binding site, especially in the case of small molecular targets, sandwich assays are generally not applicable. To overcome this limitation for the detection of these mono-epitope targets, we used a competitive assay method (Figure 4) . In a typical competitive assay, the target competes with its enzyme-labeled analogue to bind to an antibody. The more targets in the sample, the less enzyme- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 labeled analogues are bound to the antibody and yield corresponding changes in the signal readout ( Figure 4) . Note that the target and its enzyme-labeled analogues are allow to interact with the antibody simultaneously, thus the method is defined as competitive here rather than replacement. Therefore, the glucose produced by the unbound biotin-invertase conjugates was detected by PGMs and the readout could be used for the quantification of biotin in the sample. The detection can also be realized by measuring the glucose produced by the biotin-invertase conjugates bound on the MBs, but we did not choose it because a signal-off glucose signal was observed instead of signal-on in this case. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 nucleotide and buffer components, did not give any signal or interfere with the biotin detection because of the highly specific interaction between biotin and streptavidin. Having demonstrated the competitive assay method for detecting biotin as a model, we then investigated the application of the method to detect a small molecular toxin, Ochratoxin A (OTA), [30] [31] [32] which is one of the most abundant food-contaminating mycotoxins worldwide. 33,34 Because OTA lacks multiple binding sites for antibodies, it cannot be detected via the sandwich assay method shown in Figure 1 . Alternatively, the competitive assay (Figure 4b ) can be used. We found that the activity of invertase was partially inhibited in the presence of high concentrations of OTA during conjugation, so the direct contact of concentrated OTA and invertase should be minimized to avoid false positive or negative results. Therefore, instead of directly conjugating OTA and invertase to yield the OTAinvertase as the enzyme-labeled OTA analogue, we propose to conjugate OTA with DNA first to form 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 catalyze the production of glucose from sucrose (Figure 4b) . Therefore, the glucose concentration detected by the PGM was inversely related to the amount of DNA-OTA conjugates on the surface of MBs, which could be used for the calculation of the OTA concentration in the sample. This method was found to be able to detect OTA at least in the range of 0~1000 nM, and the detection limit was about 17
nM ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
